Pharmaceutical companies by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 pharmaceutical companies ranked by one-year price change, at +403%, ahead of Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%). Figures as of 18 Nov 2026, 19:33 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+403%
- Median
- +26.9%
- Combined market value
- CZK 112.57T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +403% | CZK 105.1B | CZK 299.53 | 3.08% down | 403% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +286% | CZK 210.1B | CZK 2,212.45 | 6.00% up | 286% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +241% | CZK 143.8B | CZK 2,120.56 | 1.05% down | 241% up | ||
| 4 | VeradermicsMANE · Health Care | +233% | CZK 116.7B | CZK 2,764.90 | 1.09% down | 233% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +169% | CZK 87.1B | CZK 636.10 | 2.69% down | 169% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +126% | CZK 165.8B | CZK 2,109.88 | 0.29% down | 126% up | ||
| 7 | Dianthus TherapeuticsDNTH · Health Care | +113% | CZK 107.2B | CZK 1,904.30 | 1.60% down | 113% up | ||
| 8 | TG TherapeuticsTGTX · Health Care | +107% | CZK 220.8B | CZK 1,460.99 | 4.71% up | 107% up | ||
| 9 | ViatrisVTRS · Health Care | +95.5% | CZK 525.1B | CZK 458.00 | 0.66% up | 96% up | ||
| 10 | Roivant SciencesROIV · Health Care | +90.3% | CZK 619.4B | CZK 854.81 | 0.75% down | 90% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | +88.2% | CZK 101.3B | CZK 924.90 | 1.12% down | 88% up | ||
| 12 | Amneal PharmaceuticalsAMRX · Health Care | +83.3% | CZK 169.1B | CZK 485.25 | 3.27% up | 83% up | ||
| 13 | Royalty PharmaRPRX · Health Care | +77.7% | CZK 887.1B | CZK 1,542.86 | 0.97% up | 78% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | +74.4% | CZK 1.09T | CZK 937.35 | 1.15% down | 74% up | ||
| 15 | GenmabGMAB · Health Care | +70.0% | CZK 703.6B | CZK 1,141.16 | 1.29% down | 70% up | ||
| 16 | Praxis Precision MedicinesPRAX · Health Care | +61.1% | CZK 190.7B | CZK 6,821.02 | 0.50% up | 61% up | ||
| 17 | AlkermesALKS · Health Care | +58.4% | CZK 173.4B | CZK 1,031.91 | 2.05% up | 58% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +53.6% | CZK 1.51T | CZK 473.46 | 1.66% down | 54% up | ||
| 19 | Merck & CoMRK · Health Care | +50.8% | CZK 7.53T | CZK 3,055.14 | 4.22% down | 51% up | ||
| 20 | Protagonist TherapeuticsPTGX · Health Care | +46.4% | CZK 182.2B | CZK 2,791.37 | 0.63% up | 46% up | ||
| 21 | Travere TherapeuticsTVTX · Health Care | +44.2% | CZK 107.9B | CZK 1,123.69 | 1.16% down | 44% up | ||
| 22 | Ligand PharmaceuticalsLGND · Health Care | +42.6% | CZK 133.2B | CZK 6,658.49 | 1.86% up | 43% up | ||
| 23 | Johnson & JohnsonJNJ · Health Care | +37.6% | CZK 14.65T | CZK 6,085.80 | 1.86% down | 38% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +36.7% | CZK 351B | CZK 5,467.94 | 2.10% up | 37% up | ||
| 25 | Regeneron PharmaceuticalsREGN · Health Care | +36.3% | CZK 2.17T | CZK 21,019.84 | 1.36% down | 36% up | ||
| 26 | Eli LillyLLY · Health Care | +34.9% | CZK 27.42T | CZK 30,783.85 | 2.26% down | 35% up | ||
| 27 | Bristol-Myers SquibbBMY · Health Care | +34.0% | CZK 2.71T | CZK 1,325.82 | 2.87% down | 34% up | ||
| 28 | Belite BioBLTE · Health Care | +31.0% | CZK 141.6B | CZK 3,486.55 | 0.64% down | 31% up | ||
| 29 | Mirum PharmaceuticalsMIRM · Health Care | +30.5% | CZK 133.8B | CZK 2,050.25 | 0.22% up | 31% up | ||
| 30 | Ascendis PharmaASND · Health Care | +27.8% | CZK 393.6B | CZK 6,001.03 | 0.54% down | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +26.9% | CZK 3.03T | CZK 11,959.56 | 0.62% up | 27% up | ||
| 32 | AbbVieABBV · Health Care | +25.7% | CZK 11.23T | CZK 6,353.79 | 2.47% down | 26% up | ||
| 33 | NovartisNVS · Health Care | +25.0% | CZK 6.52T | CZK 3,450.39 | 2.55% down | 25% up | ||
| 34 | United TherapeuticsUTHR · Health Care | +22.6% | CZK 548.6B | CZK 12,880.23 | 0.89% down | 23% up | ||
| 35 | Elanco Animal HealthELAN · Health Care | +20.5% | CZK 298.6B | CZK 597.39 | 3.87% up | 20% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +17.2% | CZK 336.7B | CZK 1,728.53 | 1.16% up | 17% up | ||
| 37 | BeOne MedicinesONC · Health Care | +16.8% | CZK 1.03T | CZK 8,991.97 | 2.20% down | 17% up | ||
| 38 | PfizerPFE · Health Care | +14.4% | CZK 3.56T | CZK 623.92 | 1.50% down | 14% up | ||
| 39 | Rhythm PharmaceuticalsRYTM · Health Care | +13.0% | CZK 185.3B | CZK 2,672.12 | 2.99% up | 13% up | ||
| 40 | BioMarin PharmaceuticalBMRN · Health Care | +11.3% | CZK 262.6B | CZK 1,355.64 | 4.14% up | 11% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +10.3% | CZK 135.9B | CZK 961.49 | 0.52% up | 10% up | ||
| 42 | GSKGSK · Health Care | +6.26% | CZK 2.17T | CZK 1,081.42 | 1.29% down | 6% up | ||
| 43 | Dr. Reddy's LaboratoriesRDY · Health Care | +5.27% | CZK 277.9B | CZK 333.40 | 1.32% up | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +2.41% | CZK 6.16T | CZK 3,971.91 | 2.06% down | 2% up | ||
| 45 | GrifolsGRFS · Health Care | +1.41% | CZK 127.5B | CZK 187.37 | 2.42% down | 1% up | ||
| 46 | SanofiSNY · Health Care | -4.08% | CZK 2.52T | CZK 1,050.05 | 0.70% down | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -7.37% | CZK 157.1B | CZK 2,986.05 | 1.28% down | 7% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -7.92% | CZK 164.8B | CZK 1,505.87 | 3.41% down | 8% down | ||
| 49 | Novo NordiskNVO · Health Care | -16.9% | CZK 3.86T | CZK 876.73 | 3.18% down | 17% down | ||
| 50 | Abbott LaboratoriesABT · Health Care | -17.0% | CZK 4.03T | CZK 2,325.25 | 0.19% down | 17% down | ||
| 51 | PTC TherapeuticsPTCT · Health Care | -20.2% | CZK 111.5B | CZK 1,334.95 | 0.60% down | 20% down | ||
| 52 | CytokineticsCYTK · Health Care | -20.3% | CZK 158.6B | CZK 1,138.49 | 0.93% down | 20% down | ||
| 53 | Cogent BiosciencesCOGT · Health Care | -20.3% | CZK 108.7B | CZK 624.98 | 0.86% up | 20% down | ||
| 54 | Madrigal PharmaceuticalsMDGL · Health Care | -24.0% | CZK 207.6B | CZK 8,937.35 | 4.81% down | 24% down | ||
| 55 | ABIVAXABVX · Health Care | -27.3% | CZK 162.7B | CZK 1,858.24 | 1.73% up | 27% down | ||
| 56 | ZoetisZTS · Health Care | -28.7% | CZK 771.8B | CZK 1,899.59 | 2.27% up | 29% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -35.6% | CZK 188.2B | CZK 235.28 | 0.89% down | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.1% | CZK 586.4B | CZK 2,673.01 | 1.41% down | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -42.5% | CZK 69.7B | CZK 359.55 | 0.31% up | 42% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -63.6% | CZK 102.4B | CZK 615.08 | 2.54% up | 64% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.0% | CZK 445B | CZK 3,322.24 | 4.59% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2491 CZK).
Questions and answers
Which pharmaceutical companies rank first by one-year price change?
Erasca (+403%), Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%) are the top three of the 61 pharmaceutical companies ranked by one-year price change as of 18 Nov 2026, 19:33 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by one-year price change.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by one-year price change have a combined market value of CZK 112.57T as of 18 Nov 2026, 19:33 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.